Screener
Pulse Biosciences, Inc. PLSE Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accounts payable | (9) | 1,044 |
| Accrued liabilities | 2,884 | (2,250) |
| Lease liabilities, net | (758) | (653) |
| Net cash used in operating activities | (33,304) | (26,328) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (123) | (148) |
| Purchases of intangible assets | — | (20) |
| Net cash used in investing activities | (123) | (168) |
Document
FAQ
- What is Pulse Biosciences, Inc.'s operating cash flow?
- Pulse Biosciences, Inc. (PLSE) reported operating cash flow of -$18.71M in Q2 2026.
- How has Pulse Biosciences, Inc.'s operating cash flow changed year-over-year?
- Pulse Biosciences, Inc.'s operating cash flow decreased by 46.1% year-over-year, from -$12.81M to -$18.71M.
- What is the long-term trend for Pulse Biosciences, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s operating cash flow has grown at a 0.0% compound annual growth rate (CAGR), from -$54.1M to -$54.12M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Pulse Biosciences, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude